Assignee
AVIGEN INC
US35 patents
Top patents by PatentIndex Score
US6004797ADec 21, 1999
Adenovirus helper-free recombinant AAV Virion production
AVIGEN INC95 citations98
US5962313AOct 5, 1999
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
AVIGEN INC203 citations98
US5952221ASep 14, 1999
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
AVIGEN INC115 citations98
US5858351AJan 12, 1999
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
AVIGEN INC223 citations98
US5846528ADec 8, 1998
Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
AVIGEN INC96 citations98
US6610290B2Aug 26, 2003
Adeno associated virus vectors for the treatment of a cardiomyopathy
AVIGEN INC75 citations97
US6593123B1Jul 15, 2003
Large-scale recombinant adeno-associated virus (rAAV) production and purification
AVIGEN INC110 citations97
US6531456B1Mar 11, 2003
Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
AVIGEN INC75 citations97
US6376237B1Apr 23, 2002
High-efficiency wild-type-free AAV helper functions
AVIGEN INC96 citations97
US6335011B1Jan 1, 2002
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions to treat lysosomal storage disease
AVIGEN INC79 citations97
US6200560B1Mar 13, 2001
Adeno-associated virus vectors for expression of factor VIII by target cells
AVIGEN INC179 citations97
US6001650ADec 14, 1999
High-efficiency wild-type-free AAV helper functions
AVIGEN INC259 citations97
US6391858B2May 21, 2002
Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors
AVIGEN INC38 citations96
US6325998B1Dec 4, 2001
Methods of treating disease using recombinant adeno-associated virus virions administered to muscle
AVIGEN INC75 citations96
US6309634B1Oct 30, 2001
Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)
AVIGEN INC177 citations96
US6221349B1Apr 24, 2001
Adeno-associated vectors for expression of factor VIII by target cells
AVIGEN INC136 citations96
US6211163B1Apr 3, 2001
Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors
AVIGEN INC78 citations96
US5843742ADec 1, 1998
Adeno-associated derived vector systems for gene delivery and integration into target cells
AVIGEN INC141 citations96
US6710036B2Mar 23, 2004
Induction of immune response to antigens expressed by recombinant adeno-associated virus
AVIGEN INC63 citations92
US6218180B1Apr 17, 2001
Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
AVIGEN INC25 citations92
US6027931AFeb 22, 2000
High-efficiency AA V helper functions
AVIGEN INC45 citations92
US6582692B1Jun 24, 2003
Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
AVIGEN INC100 citations91
US6365403B1Apr 2, 2002
High-efficiency AAV helper functions
AVIGEN INC21 citations91
US5945335AAug 31, 1999
Adenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequences
AVIGEN INC45 citations91
US6764845B2Jul 20, 2004
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
AVIGEN INC20 citations89
US7585875B2Sep 8, 2009
Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use
AVIGEN INC8 citations83
US6416992B1Jul 9, 2002
Compositions and methods for producing recombinant adeno-associated virus
AVIGEN INC42 citations81
US7037713B2May 2, 2006
High-efficiency wild-type-free AAV helper functions
AVIGEN INC4 citations72
US6759050B1Jul 6, 2004
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
AVIGEN INC9 citations71
US6207457B1Mar 27, 2001
Targeted nucleotide sequence delivery and integration system
AVIGEN INC9 citations71
US6242426B1Jun 5, 2001
Induction of immune response to antigens expressed by recombinant adeno-associated virus
AVIGEN INC10 citations70
US6897063B2May 24, 2005
Accessory functions for use in recombinant AAV virion production
AVIGEN INC2 citations62
US6482633B1Nov 19, 2002
Accessory functions for use in recombinant AAV virion production
AVIGEN INC2 citations62
US7534806B2May 19, 2009
Method for treating neuropathic pain and associated syndromes
AVIGEN INC2 citations51
US7622256B2Nov 24, 2009
Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1
AVIGEN INC0 citations47